Study on Surface Esterification of Cellulose Nanocrystals Their and Lipid-Lowering Effect

被引:0
|
作者
Yang, Jiachuan [1 ]
Liu, Jianxia [1 ]
Zhang, Xiaochen [2 ]
机构
[1] Shanxi Datong Univ, Coll Agr & Life Sci, 405 Xingyun St, Datong 037009, Shanxi, Peoples R China
[2] Jilin Vocat & Tech Coll, Longjing, Peoples R China
关键词
Cellulose nanocrystal; esterification modification; fat; digestion; absorption; buckwheat fiber;
D O I
10.1080/15440478.2024.2410937
中图分类号
TB3 [工程材料学]; TS1 [纺织工业、染整工业];
学科分类号
0805 ; 080502 ; 0821 ;
摘要
With the rapid development of the economy and changes in dietary structure, there is an excessive intake of high sugar and high-fat foods. To address this issue, in this study, we grafted palmitic acid onto CNC in the form of ester groups and evaluated its adsorption performance. Research had found that among these three methods, the CDI catalytic method can successfully obtain esterification modified CNC while also taking into account its environmentally friendly and pollution-free characteristics. Compared with CNC, its adsorption capacity for oil had increased, with the maximum adsorption capacity increasing from 35.80 g/g to 46.91 g/g. Meanwhile, the degree of esterification substitution of esterification modified CNC was measured, and the result was 0.03. Especially, after adding CNC-PA, the hydrolysis of fat was significantly reduced during the simulated digestion in vitro, whilst the absorption of fat in the intestine was significantly inhibited. In vivo testing also confirmed that consuming a diet containing CNC-PA significantly reduced elevated levels of triglycerides (TG) compared to the high-fat control group while long-term feeding of a diet containing CNC-PA reduced weight and fat accumulation.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Lipid-lowering drugs and homocysteine - A comparison between statins and other lipid-lowering drugs
    Jankowski, P
    Kawecka-Jaszcz, K
    ATHEROSCLEROSIS, 2004, 172 (01) : 191 - 194
  • [32] Lipid-lowering effect of berberine in human subjects and rats
    Hu, Yueshan
    Ehli, Erik A.
    Kittelsrud, Julie
    Ronan, Patrick J.
    Munger, Karen
    Downey, Terry
    Bohlen, Krista
    Callahan, Leah
    Munson, Vicki
    Jahnke, Mike
    Marshall, Lindsey L.
    Nelson, Kelly
    Huizenga, Patricia
    Hansen, Ryan
    Soundy, Timothy J.
    Davies, Gareth E.
    PHYTOMEDICINE, 2012, 19 (10) : 861 - 867
  • [33] IMPROVEMENT OF COMPLIANCE WITH LIPID-LOWERING AGENTS IMPROVEMENT OF THE COMPLIANCE OF LIPID-LOWERING MEDICATION. CONTROLLED STUDY IN COMMUNITY PHARMACY
    Andres Iglesias, J. Carlos
    Andres Rodriguez, N. Floro
    Fornos Perez, Jose A.
    FARMACEUTICOS COMUNITARIOS, 2009, 1 (03): : 92 - 98
  • [34] The effect of lipid-lowering therapy on lipid-related residual risk factors: a prospective study
    Li, Zhifan
    Gao, Yanan
    Lu, Qianhong
    Yin, Zheng
    Zhang, Shuang
    Zhang, Wenjia
    Sui, Yonggang
    Xu, Yanlu
    Li, Jianjun
    Dou, Kefei
    Qian, Jie
    Qiu, Hong
    Wu, Naqiong
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [35] Lipids abnormalities and the effect of lipid-lowering treatment in women
    Prokchorovich, E. A.
    Tkacheva, O. N.
    Majchuk, E. U.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 205 - 205
  • [36] Effect of lipid-lowering strategies on tubular cell biology
    Vrtovsnik, F
    Essig, M
    Iimura, O
    Friedlander, G
    KIDNEY INTERNATIONAL, 1999, 56 : S92 - S96
  • [37] Lipid-lowering agents and fibrinolysis:: lack of effect in vitro
    Elzaher, SM
    Pallister, CJ
    Dunn, CDR
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2001, 58 (04) : 244 - 246
  • [38] Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients
    Egede, Rasmus
    Jensen, Lisette Okkels
    Hansen, Henrik Steen
    Antonsen, Lisbeth
    Hansen, Knud Norregaard
    Junker, Anders
    Thayssen, Per
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (03) : 376 - 379
  • [39] LIPID-LOWERING DIETARY ADVICE
    ANGELICO, F
    VOLPE, R
    BRITISH MEDICAL JOURNAL, 1995, 310 (6995): : 1669 - 1669
  • [40] LIPID-LOWERING EFFECTS OF PROCETOFENE
    AFSCHRIFT, M
    METS, T
    VERDONK, G
    LANCET, 1977, 2 (8032): : 311 - 311